IBDEI0LG ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21636,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,21636,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,21636,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,21637,0)
 ;;=L21.9^^89^1035^263
 ;;^UTILITY(U,$J,358.3,21637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21637,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21637,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,21637,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,21638,0)
 ;;=L23.7^^89^1035^30
 ;;^UTILITY(U,$J,358.3,21638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21638,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,21638,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,21638,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,21639,0)
 ;;=L23.9^^89^1035^31
 ;;^UTILITY(U,$J,358.3,21639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21639,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21639,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,21639,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,21640,0)
 ;;=L24.9^^89^1035^163
 ;;^UTILITY(U,$J,358.3,21640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21640,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21640,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,21640,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,21641,0)
 ;;=L25.9^^89^1035^115
 ;;^UTILITY(U,$J,358.3,21641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21641,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21641,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,21641,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,21642,0)
 ;;=L26.^^89^1035^148
 ;;^UTILITY(U,$J,358.3,21642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21642,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,21642,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,21642,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,21643,0)
 ;;=L27.0^^89^1035^265
 ;;^UTILITY(U,$J,358.3,21643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21643,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,21643,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,21643,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,21644,0)
 ;;=L27.1^^89^1035^266
 ;;^UTILITY(U,$J,358.3,21644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21644,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,21644,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,21644,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,21645,0)
 ;;=L29.0^^89^1035^250
 ;;^UTILITY(U,$J,358.3,21645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21645,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,21645,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,21645,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,21646,0)
 ;;=L29.9^^89^1035^251
 ;;^UTILITY(U,$J,358.3,21646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21646,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,21646,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,21646,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,21647,0)
 ;;=L30.0^^89^1035^232
 ;;^UTILITY(U,$J,358.3,21647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21647,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,21647,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,21647,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,21648,0)
 ;;=L30.1^^89^1035^140
 ;;^UTILITY(U,$J,358.3,21648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21648,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,21648,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,21648,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,21649,0)
 ;;=L30.2^^89^1035^132
 ;;^UTILITY(U,$J,358.3,21649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21649,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,21649,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,21649,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,21650,0)
 ;;=L30.4^^89^1035^144
 ;;^UTILITY(U,$J,358.3,21650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21650,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,21650,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,21650,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,21651,0)
 ;;=L30.8^^89^1035^135
 ;;^UTILITY(U,$J,358.3,21651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21651,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,21651,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,21651,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,21652,0)
 ;;=L30.9^^89^1035^136
 ;;^UTILITY(U,$J,358.3,21652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21652,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21652,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,21652,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,21653,0)
 ;;=L40.0^^89^1035^253
 ;;^UTILITY(U,$J,358.3,21653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21653,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,21653,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,21653,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,21654,0)
 ;;=L40.1^^89^1035^256
 ;;^UTILITY(U,$J,358.3,21654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21654,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,21654,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,21654,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,21655,0)
 ;;=L40.2^^89^1035^11
 ;;^UTILITY(U,$J,358.3,21655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21655,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,21655,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,21655,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,21656,0)
 ;;=L40.3^^89^1035^255
 ;;^UTILITY(U,$J,358.3,21656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21656,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,21656,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,21656,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,21657,0)
 ;;=L40.4^^89^1035^157
 ;;^UTILITY(U,$J,358.3,21657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21657,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,21657,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,21657,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,21658,0)
 ;;=L40.8^^89^1035^252
 ;;^UTILITY(U,$J,358.3,21658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21658,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,21658,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,21658,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,21659,0)
 ;;=L40.9^^89^1035^254
 ;;^UTILITY(U,$J,358.3,21659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21659,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,21659,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,21659,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,21660,0)
 ;;=L50.9^^89^1035^286
 ;;^UTILITY(U,$J,358.3,21660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21660,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,21660,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,21660,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,21661,0)
 ;;=L53.8^^89^1035^147
 ;;^UTILITY(U,$J,358.3,21661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21661,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,21661,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,21661,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,21662,0)
 ;;=L53.9^^89^1035^146
 ;;^UTILITY(U,$J,358.3,21662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21662,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,21662,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,21662,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,21663,0)
 ;;=L54.^^89^1035^145
 ;;^UTILITY(U,$J,358.3,21663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21663,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,21663,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,21663,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,21664,0)
 ;;=L56.0^^89^1035^139
 ;;^UTILITY(U,$J,358.3,21664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21664,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,21664,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,21664,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,21665,0)
 ;;=L56.1^^89^1035^138
